- Biologics
- Parasiticides
- Anti-infectives
- Reproduction
- Others
Aquaculture Pharmaceuticals Market size was valued at USD 874.3 million in 2022 and is anticipated to grow at a CAGR of 7.5 % over 2023-2029. Aquaculture pharmaceuticals, also known as aqua pharmaceuticals or aqua meds, refer to a class of substances used in the aquaculture industry to promote the health and well-being of aquatic animals, particularly those raised in fish farms or other controlled aquatic environments. Aquaculture pharmaceuticals play a crucial role in preventing, diagnosing, and treating diseases and health issues that can arise in farmed fish, shellfish, and other aquatic organisms.
The increasing global demand for seafood has a significant impact on driving the revenues of the aquaculture pharmaceuticals market. As the world's population continues to grow and dietary preferences evolve, the consumption of seafood is on the rise. To meet this demand, the aquaculture industry is expanding its production capacity. However, intensifying aquaculture operations can lead to challenges related to disease outbreaks, stress, and suboptimal health conditions for farmed aquatic species. Aquaculture pharmaceuticals play a pivotal role in ensuring the health and well-being of these species, enabling sustainable and responsible aquaculture practices. Moreover, regulatory requirements exert a substantial influence on driving the aquaculture pharmaceuticals market. As governments and international bodies place increased emphasis on responsible and sustainable aquaculture practices, regulations are put in place to ensure the health and welfare of farmed aquatic species and the surrounding environment. To comply with these requirements and maintain regulatory standards, aquaculture operators turn to aquaculture pharmaceuticals as essential tools for disease control, treatment, and overall health improvement.
However, stringent regulations and approval processes for aquaculture pharmaceuticals can slow down innovation and limit the availability of effective treatments, which eventually act as a major challenge to the growth of the aquaculture pharmaceuticals market. Meanwhile, the growth of intensive aquaculture practices, including fish farming and shrimp farming that require advanced pharmaceutical solutions, creates significant opportunities for further growth of the aquaculture pharmaceuticals market. Major pharmaceutical companies are developing innovative solutions to cater to the aquaculture industry. For instance, in October 2022, Indian Immunologicals ventured into aquaculture health by launching a product line encompassing various offerings such as vaccines to meet the rising demand for healthy farmed shrimp and fish in India.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Pharmaceuticals plays a pivotal role in aquaculture to prevent and treat aquatic animals from various microbial infections. Companies are betting heavily on research and development programs to develop novel drugs that can treat new infections in aquatic animals. For instance, in 2015, PHARMAQ, a part of Zoetis, Inc., invested in to produce fish vaccines in new facility at Klofta. Furthermore, lack of generic drugs to compete with inventor drugs makes more lucrative for the aquaculture pharmaceuticals manufacturers. In addition, global increase in farmed fish production than the wild catch are projected to boost aquaculture pharmaceuticals market over the forecast period. According to Food and Agriculture Organisation of the United Nations (FAO) estimates, the farmed fish production increased by 5.6% from 66.5 Mn tonnes (2013) to 70.2 Mn tonnes (2013).
The aquaculture pharmaceuticals market size was valued at USD 874.3 million in 2022
Elanco (Eli Lilly and Company) (U.S), Intervet Inc., (Merck & Co., Inc.,) (U.S.), Bayer AG (Germany), PharmaQ AS (Zoetis, Inc
North America is the fastest-growing region for aquaculture pharmaceuticals market
Innovation in pharmaceuticals and investment in research and development of new aquaculture pharmaceuticals are some of the key opportunities for companies to enhance their revenue over the forecast years.
Innovations in delivery methods for aquaculture pharmaceuticals and integration of remote health monitoring systems are some of the major trends in the aquaculture pharmaceuticals market.
1. Executive Summary |
2. Global Aquaculture Pharmaceuticals Market Introduction |
2.1.Global Aquaculture Pharmaceuticals Market - Taxonomy |
2.2.Global Aquaculture Pharmaceuticals Market - Definitions |
2.2.1.Product |
2.2.2.Species |
2.2.3.Geography |
2.2.4.Region |
3. Global Aquaculture Pharmaceuticals Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Aquaculture Pharmaceuticals Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Aquaculture Pharmaceuticals Market By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Biologics |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Parasiticides |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Anti-infectives |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Reproduction |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6. Global Aquaculture Pharmaceuticals Market By Species, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Carps |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Salmon |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Tilapia |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Shrimp |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Catfish |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Trout |
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Others |
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
7. Global Aquaculture Pharmaceuticals Market By Geography, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa (MEA) |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Aquaculture Pharmaceuticals Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Biologics |
9.1.2.Parasiticides |
9.1.3.Anti-infectives |
9.1.4.Reproduction |
9.1.5.Others |
9.2. Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Carps |
9.2.2.Salmon |
9.2.3.Tilapia |
9.2.4.Shrimp |
9.2.5.Catfish |
9.2.6.Trout |
9.2.7.Others |
9.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.North America |
9.3.2.Europe |
9.3.3.Asia-Pacific |
9.3.4.Latin America |
9.3.5.Middle East and Africa (MEA) |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Biologics |
10.1.2.Parasiticides |
10.1.3.Anti-infectives |
10.1.4.Reproduction |
10.1.5.Others |
10.2. Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Carps |
10.2.2.Salmon |
10.2.3.Tilapia |
10.2.4.Shrimp |
10.2.5.Catfish |
10.2.6.Trout |
10.2.7.Others |
10.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.North America |
10.3.2.Europe |
10.3.3.Asia-Pacific |
10.3.4.Latin America |
10.3.5.Middle East and Africa (MEA) |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Biologics |
11.1.2.Parasiticides |
11.1.3.Anti-infectives |
11.1.4.Reproduction |
11.1.5.Others |
11.2. Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Carps |
11.2.2.Salmon |
11.2.3.Tilapia |
11.2.4.Shrimp |
11.2.5.Catfish |
11.2.6.Trout |
11.2.7.Others |
11.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.North America |
11.3.2.Europe |
11.3.3.Asia-Pacific |
11.3.4.Latin America |
11.3.5.Middle East and Africa (MEA) |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Biologics |
12.1.2.Parasiticides |
12.1.3.Anti-infectives |
12.1.4.Reproduction |
12.1.5.Others |
12.2. Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Carps |
12.2.2.Salmon |
12.2.3.Tilapia |
12.2.4.Shrimp |
12.2.5.Catfish |
12.2.6.Trout |
12.2.7.Others |
12.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.North America |
12.3.2.Europe |
12.3.3.Asia-Pacific |
12.3.4.Latin America |
12.3.5.Middle East and Africa (MEA) |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Biologics |
13.1.2.Parasiticides |
13.1.3.Anti-infectives |
13.1.4.Reproduction |
13.1.5.Others |
13.2. Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Carps |
13.2.2.Salmon |
13.2.3.Tilapia |
13.2.4.Shrimp |
13.2.5.Catfish |
13.2.6.Trout |
13.2.7.Others |
13.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.North America |
13.3.2.Europe |
13.3.3.Asia-Pacific |
13.3.4.Latin America |
13.3.5.Middle East and Africa (MEA) |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Elanco (Eli Lilly and Company) (U.S.) |
14.2.2.Intervet Inc., (Merck & Co., Inc.,) (U.S.) |
14.2.3.Bayer AG (Germany) |
14.2.4.PharmaQ AS (Zoetis, Inc.,) |
15. Research Methodology |
16. Appendix and Abbreviations |